Marijuana Stocks: Claim Your Advantage – September 18, 2017

Read This…Gain Your Advantage

The marijuana industry has come a very long way. Now, marijuana stock investors are starting to pay much more attention to a niche that…

Claim Your Advantage

Tetra Bio-Pharma Inc. (TBPMF) Ready to file Trial App to Initiate Phase 3 Trial

Tetra Bio-Pharma Inc. (“Tetra” or the “Company“) (TSX VENTURE:TBP)(TBPMF), today announces that it will be filing a clinical trial application (CTA) in the coming weeks to therapeutic products directorate (TPD) to initiate its Phase 3 clinical trial of PPP001 in terminal cancer patients. With this filing, Tetra expects to be on time with its previously announced schedule with the development of PPP001.

Click Here For Full Article

How One California County is Partnering With Cannabis

Yolo County in California has decided to find an answer to help cannabis workers in the state using the SICPATRACE solution.

Click Here For Full Article

Pursuant to an agreement between MAPH and Tetra Bio-Pharma, we were hired for a period of 90 days ending August 11, 2017 to publicly disseminate information about (TBPMF) including on the Website and other media including Facebook and Twitter. We are being paid $75,000 (CASH) for and were paid 250,000 restricted common shares of Tetra Bio-Pharma. We may buy or sell additional shares of (TBPMF) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information.PLEASE READ OUR FULL PRIVACY POLICY & TERMS OF USE & DISCLAIMER